Trademark: 79324344
Word
HUB ORGANOIDS
Status
Registered
Status Code
700
Status Date
Tuesday, November 29, 2022
Serial Number
79324344
Registration Number
6909088
Registration Date
Tuesday, November 29, 2022
Mark Type
3
Filing Date
Thursday, April 29, 2021
Published for Opposition
Tuesday, September 13, 2022

Trademark Owner History

Classifications
5 Cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; stem cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; epithelial cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; chemicals for use in scientific medical research for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; chemicals for use in scientific medical research for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; culture media for medical and veterinary use, namely, for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; culture media for medical and veterinary use, namely, for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations and substances for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx
1 Cells, stem cells, epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic and analytical preparations for use in science; chemicals used in science and industry; assays and assay preparations for scientific purposes; cell culture media for scientific research purposes
44 Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services
42 Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development services, and characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine testing services, namely, testing of pharmaceuticals; compound, drug and vaccine testing services; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine
The mark consists of a stylised representation of an organoid in blue outline to the left of the term "HUB" in blue and "ORGANOIDS" in black. The colour white represents background and/or transparent areas and is not claimed as a feature of the mark.
In the statement, line 9," cell culture reagents for scientific and research use" should be deleted.
The color(s) blue and black is/are claimed as a feature of the mark.
"ORGANOIDS"

Trademark Events
Oct 28, 2021
Sn Assigned For Sect 66a Appl From Ib
Nov 4, 2021
Limitation From Original Application Entered
Nov 5, 2021
New Application Office Supplied Data Entered
Nov 9, 2021
Application Filing Receipt Mailed
Dec 18, 2021
New Representative At Ib Received
Dec 29, 2021
Assigned To Examiner
Jan 13, 2022
Non-Final Action Written
Feb 4, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jan 14, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Feb 4, 2022
Refusal Processed By Mpu
Feb 28, 2022
Refusal Processed By Ib
Jul 14, 2022
Teas Change Of Owner Address Received
Jul 14, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 14, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 14, 2022
Teas Change Of Correspondence Received
Jul 14, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 1, 2022
Teas Response To Office Action Received
Aug 1, 2022
Correspondence Received In Law Office
Aug 1, 2022
Teas/Email Correspondence Entered
Aug 9, 2022
Approved For Pub - Principal Register
Aug 24, 2022
Notification Of Notice Of Publication E-Mailed
Sep 7, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 7, 2022
Notification Of Possible Opposition Sent To Ib
Sep 13, 2022
Published For Opposition
Sep 13, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 27, 2022
Notification Processed By Ib
Nov 29, 2022
Registered-Principal Register
Nov 29, 2022
Notice Of Registration Confirmation Emailed
Dec 19, 2022
Teas Section 7 Request Received
Feb 28, 2023
Final Disposition Notice Created, To Be Sent To Ib
Mar 23, 2023
Case Assigned To Post Registration Paralegal
Mar 23, 2023
Post Registration Action Mailed - Sec. 7
Mar 23, 2023
Teas Response To Office Action-Post Reg Received
Mar 31, 2023
Post Registration Action Mailed No Response Required
Mar 31, 2023
Correction Under Section 7 - Processed
Apr 17, 2023
Final Disposition Processed
May 9, 2023
Notice Of Updated Registration Confirmation Emailed
Apr 17, 2023
Final Disposition Notice Sent To Ib
May 9, 2023
Final Decision Transaction Processed By Ib
Jan 4, 2024
Invalidation Reviewed - No Action Required By Office
Dec 17, 2023
Partial Invalidation Of Reg Ext Protection Created
Apr 5, 2024
Change Of Owner Received From Ib
May 7, 2024
Change Of Name/Address Rec'd From Ib

Trademark Alertz updated from USPTO on 2030-01-24